α-MSH C-Terminal Tripeptide

KPV

A 3-amino acid tripeptide (Lys-Pro-Val) corresponding to the C-terminus of α-melanocyte-stimulating hormone. Premium Research Peptide.

Lysine-Proline-ValineCAS 67727-97-3
SKU KPV5Status Available
Unit price$45.00
Available for research
Select dose

Same compound, available in multiple strengths.

5 mg
Volume discounts

Choose your research quantity for tiered pricing.

1 vial · 0% off$45.00 / vial
$45.00Standard price
Batch documentationIndependent Certificate of Analysis availablePP-B1-KPV5 · August 10, 2026
Free shipping on orders over $150.00All orders ship in discreet, unlabeled packaging.
Product profile

Clear information for better research.

Product identity, supporting information and handling context in one considered interface.

01 / Overview

Product description

A 3-amino acid tripeptide (Lys-Pro-Val) corresponding to the C-terminus of α-melanocyte-stimulating hormone. Premium Research Peptide.

Molecular Profile

  • Type: α-MSH C-terminal tripeptide
  • Length: 3 amino acids
  • Sequence: Lys-Pro-Val (KPV)
  • Molecular Formula: C16H30N4O4
  • Molecular Weight: 342.43 Da
  • PubChem CID: 3081702
  • Storage: Lyophilized -20°C protected from light. Reconstituted 2-8°C, use within 30 days.

Important notice. Offered exclusively for in vitro research use. Not intended for human or animal consumption.

02 / Product record

Catalog details

Compound
KPV
Selected dose
5 mg
SKU
KPV5
Category
α-MSH C-Terminal Tripeptide
Availability
In stock
Technical references

A visual language for precision.

Supporting visuals remain separate from the primary product image so each asset has a clear role.

PubChem structure
2D molecular structure — KPV
PubChem structure for the current product record.
Molecular representation
Molecular representation — KPV
Molecular representation for the current product record.
Important notice

Research use only.

Offered exclusively for in vitro/laboratory research. Not intended for human or veterinary use. Purchasers must be qualified researchers aged 21 or older.